Skip to content
OpenCapital
Get started

PROCEPT BioRobotics Corporation PRCT Number of Exercisable Options

Number of Exercisable Options at other companies

Absci Corporation logo
Absci CorporationABSI
12M+36.7%
UFP Technologies logo
UFP TechnologiesUFPT
59.1K—

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-22.5%
Enterprise value$1.25B—
P/S3.7×—

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's number of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's number of exercisable options?
PROCEPT BioRobotics Corporation (PRCT) reported number of exercisable options of $44.7M in Q1 2026.
How has PROCEPT BioRobotics Corporation's number of exercisable options changed year-over-year?
PROCEPT BioRobotics Corporation's number of exercisable options decreased by 72.5% year-over-year, from $162.3M to $44.7M.
What is the long-term trend for PROCEPT BioRobotics Corporation's number of exercisable options?
Over 5 years (2020 to 2025), PROCEPT BioRobotics Corporation's number of exercisable options has grown at a 54.6% compound annual growth rate (CAGR), from $6.9M to $61M.
What does number of exercisable options mean?
The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.